A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors	Solid Tumors	Enrolling by invitation	Phase 1 / Phase 2	2025-05-28		NCT06992687

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Huazhong University of Science and Technology	83
Hunan Cancer Hospital	66
Peking University Cancer Hospital & Institute	189
Shandong Cancer Hospital and Institute	71
Shanghai Huaota Biopharmaceutical Co., Ltd.	10
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	164
The Second Affiliated Hospital of Harbin Medical University	36
Zhejiang Cancer Hospital	142

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking University Cancer Hospital	Beijing	China	21